| Old Articles: <Older 13331-13340 Newer> |
|---|
 |
The Motley Fool
March 30, 2006
David Compton |
Glaxo's New Flu-Fighting Ammo The FDA certifies the drugmaker's Relenza for defense as well as offense. For investors seeking to give their portfolios a shot in the arm, now might be the time to take a closer look at Glaxo.   |
The Motley Fool
March 30, 2006
Seth Jayson |
GM Pushed Closer to the Edge As Delphi moves closer to a strike, GM shareholders should watch out. |
The Motley Fool
March 30, 2006
Seth Jayson |
This Month's Losers Learn to love the losers. Sometimes, they're your best bet. ViroPharma... WorldSpace... Novell... True Religion... Sadia... Brasil Telecom... |
The Motley Fool
March 30, 2006
Stephen D. Simpson |
Dangerous Half-Truths of Investing Not all Wall-Street advice can be neatly labeled "good" or "bad." Some advice is a bit of both -- and that can be the most dangerous of all. Don't double down... Buy what you know... |
The Motley Fool
March 30, 2006
Stephen D. Simpson |
Here's Hoping Patterson Keeps Pumping The land drilling market is still strong, but this is a risky play on the space. This is not a widows-and-orphans stock. |
The Motley Fool
March 30, 2006
Alyce Lomax |
A Towering Anachronism? Old-school companies like Tower and Musicland clearly still have some fight left in 'em -- but it seems so far that digital dominators like Apple and Amazon have little reason to worry. Investors, take note. |
The Motley Fool
March 30, 2006
Stephen D. Simpson |
MSC Industrial: The Respect Continues Solid growth all around and more opportunities for expansion are encouraging. What's more, while this stock is absolutely sensitive to economic activity, it has survived the ups and downs of the past. |
The Motley Fool
March 30, 2006
Stephen D. Simpson |
Resources Connection Gets Some Static Underperformance in a seasonally weak quarter isn't a great reason to panic. Investors, you might find that this stock is more enticing at its newly lowered price. |
The Motley Fool
March 30, 2006
Stephen D. Simpson |
Arrow International's Dead Release Results at this medical device manufacturer look better than they really are. Investors, take note. |
The Motley Fool
March 30, 2006
Brian Gorman |
Chewing Gum Goes Scientific Wrigley's scientific pursuits could provide it with valuable marketing claims. Investors might be quick to write off Wrigley's initiative, but the confectionary giant's research could provide it with marketing ammunition that plays well with the current mind-set of U.S. consumers. |
| <Older 13331-13340 Newer> Return to current articles. |
